Skip to main content

Q Founder Series | The Drug Development Journey: From Discovery to Regulatory Approval

Tuesday, May 7, 2024 | 12:00 PM - 1:00 PM CT
Online

Join us as we learn about the complex drug development journey from the initial discovery of therapeutic targets to navigating the important steps of preclinical research and the clinical research phases that lead to regulatory approval.

 

SPEAKER BIO:

Kathleen Wisemandle

Founder | Strategic Advisor and Executive Coach | Aspire To Grow Consulting

Kathleen has 30+ years in the Biopharma space and has been involved in a range of critical R&D areas, including IND planning, protocol development, operational planning, team development and comprehensive risk identification and mitigation planning, with a particular focus on optimizing vendor selection, managing Key Opinion Leaders (KOLs), and ensuring regulatory compliance.

Audience

  • Faculty/Staff
  • Student
  • Post Docs/Docs
  • Graduate Students

Contact

Sonia Kim
(847) 467-0446
Email

Interest

Add Event To My Group

Please sign-in